Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Presentations/ Publications

ASCO Poster Presentation by Dr. Anthony Greco “Unknown Primary Cancer (UPC): Accuracy of Tissue of Origin Prediction by Molecular Profiling”, June 1, 2009

Educational Opportunities

CancerCare Telephone Workshop “When the Diagnosis is Cancer of Unknown Primary: Guidelines for Care” Friday, June 26, 2009

Upcoming Events

CAP ‘09 –
THE Pathologists’ MeetingTM
College of American Pathologists
October 11-14, 2009
Washington, DC

bioTheranostics develops innovative molecular diagnostic oncology tests that provide valuable diagnostic and prognostic information to assist physicians in identifying the cancer therapies that will be most effective for each individual patient.

THEROS CancerTYPE ID® provides molecular classification of uncertain or unknown cancers to guide physicians in determination of the primary cancer site and aides in the selection of therapeutic options.

THEROS Breast Cancer IndexSM predicts breast cancer recurrence risk based on proprietary molecular biomarkers, resulting in more appropriate treatment decisions.